Documentation scienceplus.abes.fr version Bêta

À propos de : CORRECTION        

AttributsValeurs
type
Is Part Of
Subject
Title
  • CORRECTION
has manifestation of work
Abstract
  • Messrs. Roche Products Limited have been kind enough to point out that in a report of a meeting of the Society of Anaesthetists of the South-Western Region, published on page 239 of the May issue, the approved name of Arfonad was given as “Verazide.” This is, in fact, incorrect, the approved name for Arfonad being trimetaphan (camphorsulphonate).
article type
publisher identifier
  • 28.9.437-s
is part of this journal



Alternative Linked Data Documents: ODE     Content Formats:       RDF       ODATA       Microdata